Table of Content



Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Animal type
1.1.3 Regional Scope
1.1.4 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Asia Pacific
1.3.5.4 Data for primary interviews in Latin America
1.3.5.5 Data for primary interviews in Middle East and Africa
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Report Objectives
Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 Animal Vaccines Market Outlook, 2016 - 2028 (USD Million)
2.2 Segment Outlook
2.3 Animal Vaccines Market Summary, 2020
Chapter 3 Animal Vaccines Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Regulatory Framework
3.4 Animal Vaccines Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Rising livestock population and pet ownership
3.4.1.2 Increasing disease outbreaks
3.4.1.3 Rising R&D and manufacturing procedural advancements
3.4.1.4 Growing demand for animal-derived food products
3.4.1.5 regulatory mandates
3.4.2 Market restraint analysis
3.4.2.1 Government intervention
3.4.2.2 Short product exclusivity period
3.4.2.3 high storage cost of vaccines
3.5 Animal Vaccines Market Analysis Tools: Porters
3.5.1 Supplier Power: Low
3.5.2 Buyer Power: moderate
3.5.3 THREAT OF SUBSTITUTES: Low
3.5.4 THREAT OF NEW ENTRANTS: Moderate
3.5.5 Competitive Rivalry: High
3.6 PESTEL Analysis
3.6.1 Political landscape
3.6.2 Economic landscape
3.6.3 Social landscape
3.6.4 Technology landscape
3.6.5 Legal landscape
3.7 Major Deals & Strategic Alliances Analysis
3.7.1 Mergers & Acquisitions
3.7.2 Product Launch
3.7.3 Expansion
Chapter 4 Animal Vaccines Market: Competitive Analysis
4.1 Market Participation Categorization
4.2 Public Companies
4.2.1 Company market share/position analysis
4.2.2 Competitive Dashboard Analysis
4.3 Private Companies
4.3.1 List of key emerging companies
Chapter 5 Animal Vaccines Market: COVID Impact Analysis
5.1 Impact of Disease Outbreak on The Market
Chapter 6 Animal Vaccines Market: Product Estimates & Trend Analysis
6.1 Product Market Share Analysis, 2020 & 2028
6.2 Product Dashboard
6.3 Global Animal Vaccines Market, By Product, 2016 to 2028
6.3.1 Attenuated live vaccines
6.3.1.1 Attenuated live vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
6.3.2 Inactivated vaccines
6.3.2.1 Inactivated vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
6.3.3 Subunit vaccines
6.3.3.1 Subunit vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
6.3.4 DNA vaccines
6.3.4.1 DNA vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
6.3.5 Recombinant vaccines
6.3.5.1 Recombinant vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
Chapter 7 Animal Vaccines Market: Animal type Estimates & Trend Analysis
7.1 Animal Type Market Share Analysis, 2020 & 2028
7.2 Animal Type Dashboard
7.2.1 Poultry
7.2.1.1 Poultry Market by disease type
7.2.1.2 Infectious bronchitis
7.2.1.2.1 INFECTIOUS BRONCHITIS market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.1.3 Avian influenza
7.2.1.3.1 Avian influenza market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.1.4 Marek’s disease
7.2.1.4.1 Marek’s disease market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.1.5 Newcastle disease
7.2.1.5.1 NEWCASTLE DISEASE market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.1.6 Salmonella
7.2.1.6.1 Salmonella market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.1.7 Others
7.2.1.7.1 Others market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.2 Aqua
7.2.2.1 Aqua Market by disease type
7.2.2.2 Bacterial
7.2.2.2.1 Bacterial market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.2.3 Viral
7.2.2.3.1 Viral market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.2.4 Others
7.2.2.4.1 Others market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.3 Ruminants
7.2.3.1 Ruminants Market by disease type
7.2.3.2 Foot & mouth disease (FMD)
7.2.3.2.1 FOOT & MOUTH DISEASE (FMD) market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.3.3 Lumpy skin
7.2.3.3.1 Lumpy skin market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.3.4 Rotavirus
7.2.3.4.1 Rotavirus market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.3.5 Coronavirus
7.2.3.5.1 CORONAVIRUS drugs market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.3.6 E. COLI
7.2.3.6.1 E. COLI market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.3.7 Others
7.2.3.7.1 Others market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.4 Companion
7.2.4.1 Canine Market by disease type
7.2.4.2 Distemper
7.2.4.2.1 DISTEMPER market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.4.3 Kennel cough
7.2.4.3.1 Kennel cough market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.4.4 Parvovirus
7.2.4.4.1 Parvovirus market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.4.5 Canine herpes
7.2.4.5.1 CANINE HERPES drugs market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.4.6 Lyme disease
7.2.4.6.1 Lyme disease market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.4.7 Rabies
7.2.4.7.1 Rabies market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.4.8 Feline Market by disease type
7.2.4.9 Rhinotracheitis
7.2.4.9.1 Rhinotracheitis market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.4.10 Calicivirus
7.2.4.10.1 Calicivirus market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.4.11 Corona virus
7.2.4.11.1 Corona virus market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.4.12 Panleukopenia
7.2.4.12.1 Panleukopenia market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.4.13 Rabies
7.2.4.13.1 Rabies market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.5 Swine
7.2.5.1 Swine market estimates and forecasts, by disease type
7.2.5.2 Swine influenza
7.2.5.2.1 swine influenza market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.5.3 Classical Swine Fever (CSF)
7.2.5.3.1 CSF market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.5.4 Porcine Parvovirus (PPV)
7.2.5.4.1 PPV market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.5.5 Porcine Circovirus Type 2 (PCV2)
7.2.5.5.1 PCV2 market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.5.6 M. Hyo
7.2.5.6.1 M.Hyo market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.5.7 Actinobacillus Pleuropneumoniae
7.2.5.7.1 Actinobacillus Pleuropneumoniae market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.5.8 PRRS
7.2.5.8.1 PRRS market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.5.9 Foot & mouth disease
7.2.5.9.1 FMD disease market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.5.10 Pseudorabies
7.2.5.10.1 pseudorabies market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.5.11 PEDV (coronavirus)
7.2.5.11.1 PEDV market estimates and forecasts, 2016 - 2028 (USD Million)
7.2.5.12 Others
7.2.5.12.1 Others market estimates and forecasts, 2016 - 2028 (USD Million)
Chapter 8 Animal Vaccines Market: Regional Estimates & Trend Analysis, by, Product, Animal Type
8.1 Regional Market Snapshot
8.2 North America
8.2.1 North America Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Animal Vaccines market estimates and forecasts, 2016 - 2028(USD Million)
8.2.3 Canada
8.2.3.1 Canada Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
8.3 Europe
8.3.1 Europe Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. Animal Vaccines market estimates and forecasts, 2016 - 2028(USD Million)
8.3.3 Germany
8.3.3.1 Germany Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
8.3.4 France
8.3.4.1 France Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
8.3.5 Italy
8.3.5.1 Italy Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
8.3.6 Spain
8.3.6.1 Spain Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
8.4.2 Japan
8.4.2.1 Japan Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
8.4.3 China
8.4.3.1 China Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
8.4.4 India
8.4.4.1 India Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
8.4.5 Australia
8.4.5.1 Australia Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
8.5 Latin America
8.5.1 Latin America Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
8.5.4 Argentina
8.5.4.1 Argentina Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
8.6 MEA
8.6.1 MEA Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia Animal Vaccines market estimates and forecasts, 2016 - 2028 (USD Million)
Chapter 9 Company Profiles
9.1 Merck & Co., Inc.
9.1.1 Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.2 Zoetis
9.2.1 Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.3 Boehringer Ingelheim International GmbH
9.3.1 Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.4 Virbac
9.4.1 Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.5 Biog?nesis Bag?
9.5.1 Company overview
9.5.2 FINANCIAL PERFORMANCE
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.6 Indian Immunologicals Ltd.
9.6.1 Company overview
9.6.2 Product benchmarking
9.6.3 Strategic initiatives
9.7 Elanco
9.7.1 Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.8 Ceva
9.8.1 Company overview
9.8.2 FINANCIAL PERFORMANCE
9.8.3 R&D Investment
9.8.4 Product benchmarking
9.8.5 Strategic initiatives
9.9 Phibro Animal Health Corporation
9.9.1 Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.10 Neogen Corporation
9.10.1 Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.11 Intas Pharmaceuticals Ltd.
9.11.1 Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.12 Ourofino Sa?de Animal
9.12.1 Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives



List of Figures



Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Primary interviews in North America
Fig. 6 Primary interviews in Europe
Fig. 7 Primary interviews in Asia Pacific
Fig. 8 Primary interviews in Latin America
Fig. 9 Primary interviews in Middle East and Africa
Fig. 10 Market research approaches
Fig. 11 Value-chain-based sizing & forecasting
Fig. 12 QFD modeling for market share assessment
Fig. 13 Market formulation & validation
Fig. 14 Commodity flow analysis
Fig. 15 Animal Vaccines market revenue, 2016 - 2028 (USD Million)
Fig. 16 Animal vaccines market snapshot (USD Million)
Fig. 17 Penetration & growth prospect mapping
Fig. 18 Animal vaccines market dynamics
Fig. 19 Animal vaccines market driver impact
Fig. 20 Estimated pet population in the U.S., 2015 - 2019 (million)
Fig. 21 Animal Vaccines market restraint impact
Fig. 22 Strategy mapping
Fig. 23 Market participant categorization
Fig. 24 Company market position analysis
Fig. 25 Competitive dashboard analysis
Fig. 26 Animal vaccines market: Product movement analysis
Fig. 27 Animal vaccines market product dashboard
Fig. 28 Animal vaccines market by product
Fig. 29 Global attenuated live vaccines market, 2016 - 2028 (USD Million)
Fig. 30 Global inactivated vaccines market, 2016 - 2028 (USD Million)
Fig. 31 Global subunit vaccines market, 2016 - 2028 (USD Million)
Fig. 32 Global DNA vaccines market, 2016 - 2028 (USD Million)
Fig. 33 Global recombinant vaccines market, 2016 - 2028 (USD Million)
Fig. 34 Animal vaccines market: Animal type movement analysis
Fig. 35 Animal vaccines animal type dashboard
Fig. 36 Global infectious bronchitis market, 2016 - 2028 (USD Million)
Fig. 37 Global avian influenza market, 2016 - 2028 (USD Million)
Fig. 38 Global Marek’s disease market, 2016 - 2028 (USD Million)
Fig. 39 Global newcastle disease market, 2016 - 2028 (USD Million)
Fig. 40 Global salmonella market, 2016 - 2028 (USD Million)
Fig. 41 Global bacterial market, 2016 - 2028 (USD Million)
Fig. 42 Global viral market, 2016 - 2028 (USD Million)
Fig. 43 Global others market, 2016 - 2028 (USD Million)
Fig. 44 Global foot & mouth disease (FMD) market, 2016 - 2028 (USD Million)
Fig. 45 Global lumpy skin market, 2016 - 2028 (USD Million)
Fig. 46 Global Rotavirus market, 2016 - 2028 (USD Million)
Fig. 47 Global corona virus market, 2016 - 2028 (USD Million)
Fig. 48 Global e.coli market, 2016 - 2028 (USD Million)
Fig. 49 Global others market, 2016 - 2028 (USD Million)
Fig. 50 Global distemper market, 2016 - 2028 (USD Million)
Fig. 51 Global kennel cough market, 2016 - 2028 (USD Million)
Fig. 52 Global Parvovirusmarket, 2016 - 2028 (USD Million)
Fig. 53 Global canine herpes market, 2016 - 2028 (USD Million)
Fig. 54 Global lyme disease market, 2016 - 2028 (USD Million)
Fig. 55 Global rabies market, 2016 - 2028 (USD Million)
Fig. 56 Global rhinotracheitis market, 2016 - 2028 (USD Million)
Fig. 57 Global calcivirus market, 2016 - 2028 (USD Million)
Fig. 58 Global corona virus market, 2016 - 2028 (USD Million)
Fig. 59 Global panleukopenia market, 2016 - 2028 (USD Million)
Fig. 60 Global rabies market, 2016 - 2028 (USD Million)
Fig. 61 Global swine influenza market, 2016 - 2028 (USD Million)
Fig. 62 Global classical swine fever market, 2016 - 2028 (USD Million)
Fig. 63 Global Porcine Parvovirus (PPV) drugs market, 2016 - 2028 (USD Million)
Fig. 64 Global Porcine Circovirus type 2 (PCV2) market, 2016 - 2028 (USD Million)
Fig. 65 Global M.Hyo market, 2016 - 2028 (USD Million)
Fig. 66 Global Actinobacillus Pleuropneumoniae market, 2016 - 2028 (USD Million)
Fig. 67 Global PRRS market, 2016 - 2028 (USD Million)
Fig. 68 Global Foot & mouth disease market, 2016 - 2028 (USD Million)
Fig. 69 Global pseudorabies market, 2016 - 2028 (USD Million)
Fig. 70 Global PEDV (coronavirus) market, 2016 - 2028 (USD Million)
Fig. 71 Global others market, 2016 - 2028 (USD Million)
Fig. 72 Regional market place: Key takeaways
Fig. 73 Regional outlook, 2020 & 2028
Fig. 74 North America Animal Vaccines market, 2016 - 2028 (USD Million)
Fig. 75 U.S. Animal Vaccines market, 2016 - 2028 (USD Million)
Fig. 76 Canada Animal Vaccines market, 2016 - 2028 (USD Million)
Fig. 77 Europe Animal Vaccines market, 2016 - 2028 (USD Million)
Fig. 78 U.K. Animal Vaccines market, 2016 - 2028 (USD Million)
Fig. 79 Germany Animal Vaccines market, 2016 - 2028 (USD Million)
Fig. 80 France Animal Vaccines market, 2016 - 2028 (USD Million)
Fig. 81 Italy Animal Vaccines market, 2016 - 2028 (USD Million)
Fig. 82 Spain Animal Vaccines market, 2016 - 2028 (USD Million)
Fig. 83 Asia Pacific Animal Vaccines market, 2016 - 2028 (USD Million)
Fig. 84 Japan Animal Vaccines market, 2016 - 2028 (USD Million)
Fig. 85 China Animal Vaccines market, 2016 - 2028 (USD Million)
Fig. 86 India Animal Vaccines market, 2016 - 2028 (USD Million)
Fig. 87 Australia Animal Vaccines market, 2016 - 2028 (USD Million)
Fig. 88 Latin America Animal Vaccines market, 2016 - 2028 (USD Million)
Fig. 89 Brazil Animal Vaccines market, 2016 - 2028 (USD Million)
Fig. 90 Mexico Animal Vaccines market, 2016 - 2028 (USD Million)
Fig. 91 Argentina Animal Vaccines market, 2016 - 2028 (USD Million)
Fig. 92 MEA Animal Vaccines market, 2016 - 2028 (USD Million)
Fig. 93 South Africa Animal Vaccines market, 2016 - 2028 (USD Million)
Fig. 94 Saudi Arabia Animal Vaccines market, 2016 - 2028 (USD Million)


List of Tables



TABLE 1 North America veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 2 North America veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
TABLE 3 U.S. veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 4 U.S. veterinary vaccines market, by animal type, 2016 - 2028 (USD million)
TABLE 5 Canada veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 6 Canada veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
TABLE 7 Europe veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 8 Europe veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
TABLE 9 U.K. veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 10 U.K. veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
TABLE 11 Germany veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 12 Germany veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
TABLE 13 France veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 14 France veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
TABLE 15 Italy veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 16 Italy veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
TABLE 17 Spain veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 18 Spain veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
TABLE 19 Asia Pacific veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 20 Asia Pacific veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
TABLE 21 Japan veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 22 Japan veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
TABLE 23 China veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 24 China veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
TABLE 25 India veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 26 India veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
TABLE 27 Australia veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 28 Australia veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
TABLE 29 Latin America veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 30 Latin America veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
TABLE 31 Brazil veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 32 Brazil veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
TABLE 33 Mexico veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 34 Mexico veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
TABLE 35 Argentina veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 36 Argentina veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
TABLE 37 MEA veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 38 MEA veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
TABLE 39 South Africa veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 40 South Africa veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)
TABLE 41 Saudi Arabia veterinary vaccines market, by product, 2016 - 2028 (USD Million)
TABLE 42 Saudi Arabia veterinary vaccines market, by animal type, 2016 - 2028 (USD Million)